OUE Healthcare Limited’s subsidiary, O2 Healthcare Group, has launched Singapore’s first private sleep laboratory, O2 SleepWell Laboratory, to provide advanced sleep medicine services. The SleepWell Lab, operated by O2 SleepWell Pte. Ltd., offers diagnostic and therapeutic care for sleep disorders, including sleep apnoea. This initiative is part of a broader effort to address sleep health, a growing concern in Singapore.
The launch coincides with a memorandum of understanding with HSBC Life, aiming to expand access to sleep diagnostic studies and treatments for HSBC Life customers. This collaboration seeks to make medically necessary sleep treatments more accessible through insurance partnerships.
Chairman of OUE Healthcare, Lee Yi Shyan, highlighted the importance of sleep in preventive health care, stating, “Singapore has placed growing emphasis on preventive care. Data and clinical experience show that many Singaporeans are chronically sleep-deprived.” The SleepWell Lab aims to support Singapore’s preventive health agenda by offering comprehensive sleep health services.
The SleepWell Lab collaborates with Cura Day Surgery Centre and Parkway East Hospital to conduct overnight sleep studies, providing patients with flexible options for their diagnostic needs. The lab’s integrated approach ensures a seamless patient experience, from diagnosis to ongoing treatment, with a team of sleep technologists under one roof.
Dr Swee Yong Peng, CEO of O2 Healthcare Group, emphasised the lab’s role in shaping the future of sleep health, stating, “We are building an integrated ecosystem that supports each person through every stage of their sleep health journey.”
The launch of the SleepWell Lab and its collaborations are not expected to materially impact the company’s financials for the year ending 31 December 2026.
